Clinical trials
Endometriosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
| Completed | 15 |
| Recruiting | 8 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 4 |
| Bayer | 3 |
| Ipsen | 3 |
| Guangdong Women and Children Hospital | 2 |
| Hope Medicine (Nanjing) Co., Ltd | 2 |
| Peking Union Medical College Hospital | 2 |
| Zhujiang Hospital | 2 |
| AstraZeneca | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Bio Genuine (Shanghai) Biotech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometriosis | 45 |
| Adenomyosis | 6 |
| Leiomyoma | 4 |
| Uterine Cervical Neoplasms | 4 |
| Dysmenorrhea | 3 |
| Endometrial Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Infertility | 2 |
| Recurrence | 2 |
| Choriocarcinoma | 1 |
Trials
Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.